ETS1 and cancer: Overall, data from such studies have often linked ETS1 expression to advanced state of epithelial cancers with poorer differentiation, higher invasive activity and angiogenesis, an increased risk to metastasis and a higher tendency to acquire drug resistance–all hallmark features of cancer.